entertainment -WSS

entertainment

author：comprehensive 2025-10-04 03:59:55 - browse：41554

A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT — A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

Next stop: Beacon Hill.

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： FDA warns J&J's Abiomed: We will regulate your software

knowledge

focus

WSS

CEOs share strategies for surviving biotech slump

Commercial surrogacy can be ethical, despite pope’s claims

STAT Readout Newsletter: Today's biggest biotech updates

UnitedHealth’s board chair also owns a personal investment firm

How climate

How climate

hotspot

entertainment

knowledge

Medical records are filled with copy

STAT Summit: GSK CEO on pharma giant's new direction

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

STAT Summit: GSK CEO on pharma giant's new direction

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cybersecurity threat forces Lurie Children's to take systems offline

Virginia high school admissions case could be legal follow

What we need to know about Arena Bioworks

focus

UnitedHealth’s board chair also owns a personal investment firm

HHS leader on health, climate change and biopharma emissions

Studies point to risks of excluding people with obesity from drug trials

Vertigo drug brings hope for rare neuron disorder, Niemann

FDA struggles to regulate food additives, sometimes for decades

Cognito secures funding to test medical device for Alzheimer's

knowledge

focus

hotspot

entertainment